letter-to-apa-20110128

Upload: project-on-government-oversight

Post on 08-Apr-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/7/2019 letter-to-apa-20110128

    1/3

    28 January 2011

    Carolyn B. Robinowitz

    Interim Editor,

    Psychiatric News

    Letter to Editor

    Texts Provenance Remains in Dispute

    Writing for the American Psychiatric Association (APA), Mark Moran claimed APPI

    Documents Refute Claims About Texts Authorship (Psychiatric News 21 January 2011; Vol

    46/2, p.1). The nominal authors of the book (Recognition and Treatment of Psychiatric

    Disorders: A Psychopharmacology Handbook for Primary Care) are Charles Nemeroff and Alan

    Schatzberg. We remain unconvinced of their authorship, for the following reasons.

    Mr. Moran quoted another APA spokesperson, Mr. Ron McMillen, to the effect that Drs.

    Nemeroff and Schatzberg were actively involved in every stage of the books development.

    Note, however, that he did not venture to say they wrote the initial drafts or indeed any drafts.

    The released 49-page sample chapter draft provided by Diane Coniglio and Sally Laden,

    employees of Scientific Therapeutics Information, Inc (STI), is largely reproduced verbatim in

    the Handbook. That there are drafts with the nominal authors margin notes does not establish

    who actually wrote the Handbook. It is standard procedure for the ghostwriting company,

    Scientific Therapeutics Information (STI), to provide initial drafts that are reviewed by the

    contracting corporation (here, SmithKlineBeecham, now GlaxoSmithKline - GSK) before being

    released to the nominal authors.

    STI is a commercial service entity, not a scientific institute. Their stated mission is to maximize

    credibility for their clients products. It is, therefore, no surprise that efforts to reach STI by

    Psychiatric News were not successful. The APAs spokespersons, Dr. James Scully and Mr. Ron

    McMillen, quoted in Mr. Morans article, have reached premature closure based on limited

    evidence. To bring into full view the most significant evidence for this debate would require de-

    designation of numerous confidential documents from both GSK and STI, as part of Paxil

    litigation. GSK, however, regularly invokes the Trade Secrets Act to ensure that the documents

    remain confidential and that their key opinion leaders are protected from exposure.

    Finally, we take issue with the claim in Mr. Morans article that Drs. Nemeroff and Schatzberg

    were not remunerated by GSK for any of this work. Note that there is no mention of any

    indirect payments they may have received through the unrestricted educational grant to STI.

    Such arrangements are quite common.

    We call on the APA/APPI to release all the key documents. The contract between STI and GSK

    will reveal how much influence GSK had on the content and tone of the book, and the role of

  • 8/7/2019 letter-to-apa-20110128

    2/3

    GSK in approving drafts. Correspondence between Drs. Nemeroff and Schatzberg and STI will

    make it clear whether they followed the contract. Transparency also requires release of any GSK

    marketing/ business plans for the Handbook; the legal release form transferring ownership from

    GSK to the authors and APPI; marketing activities of GSK sales representatives detailing the

    Handbook; and correspondence among all parties regarding the unrestricted educational grant.

    This case highlights the need for disclosure if we ever are to understand the scale of corporate

    influence on academic publishing. We look forward to Congressional action to require the

    release of these documents.

    Bernard Carroll, M.B., Ph.D.

    Professor and Chairman Emeritus

    Department of Psychiatry and Behavioral SciencesDuke University Medical Center

    Durham, NC 27710

    E-mail [email protected] or [email protected]

    Telephone 831-626-1467

    Robert T. Rubin, M.D., Ph.D. * Dr. Rubin is corresponding author.*

    Distinguished Professor and Vice Chair

    Department of Psychiatry and Biobehavioral Sciences

    David Geffen School of Medicine at UCLA

    Los Angeles, CA 90073

    Distinguished Life Fellow

    American Psychiatric Association

    E-mail [email protected]

    Telephone 310-268-3319

    Leemon B. McHenry, Ph.D.

    Department of Philosophy

  • 8/7/2019 letter-to-apa-20110128

    3/3

    California State University, Northridge

    Northridge, CA 91330-8253

    E-mail [email protected]